Home
Storia in 3 fonti
U.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud its prospects
The shot made by Gilead Sciences nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take.
- ·
cnbc.com
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.
- ·
scmp.com
US approves Gilead’s twice-yearly shot for HIV prevention
Lenacapavir was nearly 100 per cent effective in preventing HIV in clinical trials.
- ·
fortune.com
U.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud its prospects
The shot made by Gilead Sciences nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take.